Identification of novel genetic loci for risk of multiple myeloma by functional annotation

Affiliations

• ¹ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ² Department of Epidemiology & Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
• ³ Division of Hematology/Oncology, Division of Hematology/Oncology, Department of Medicine, School of Medicine, Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine, Irvine, CA, USA.
• ⁴ Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ⁵ Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.
• ⁶ Department of Biology, University of Pisa, Pisa, Italy.
• ⁷ Genomic Oncology Area, GENYO. Centre for Genomics and Oncological Research: Pfizer / University of Granada / Andalusian Regional Government, PTS, Granada, Spain.
• ⁸ Instituto de Investigación Biosanitaria IBs.Granada, Granada, Spain.
• ⁹ Department of Biochemistry and Molecular Biology I, University of Granada, Granada, Spain.
• ¹⁰ Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.
• ¹¹ CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
• ¹² Centre for Individualised Infection Medicine (CiiM) & TWINCORE, joint ventures between the Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School (MHH), Hannover, Germany.
• ¹³ Department for Immunology & Metabolism, Life and Medical Sciences Institute (LIMES), University of Bonn, Bonn, Germany.
• ¹⁴ National Research Centre for the Working Environment, Copenhagen, Denmark.
• ¹⁵ Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.
• ¹⁶ Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
• ¹⁷ Division of Biomedical Statistics & Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
• ¹⁸ Department of Hematology, Semmelweis University, Budapest, Hungary.
• ¹⁹ Molecular Diagnostics and Clinical Research Unit, Institute of Regional Health Research, University Hospital of Southern Denmark, Odense, Denmark.
• ²⁰ Institute of Regional Research, University of Southern Denmark, Odense, Denmark.
• ²¹ Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
• ²² Department of Hematology, Transplantology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
• ²³ Hospital Universitario 12 de Octubre, Instituto de Investigación del Hospital Universitario 12 de Octubre, 28041, Madrid, Spain.
• ²⁴ Department of Haematology & Transplantology, Medical University of Gdańsk, Gdańsk, Poland.
• ²⁵ Division of Hematology and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
• ²⁶ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
• ²⁷ Department of Lymphoproliferative Diseases, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
• ²⁸ Cancer Control Research, BC Cancer, Vancouver, BC, Canada.
• ²⁹ Program in Epidemiology, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ³⁰ Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ³¹ Department of Hematology, Warmian-Masurian Cancer Center of The Ministry Of The Interior And Administration's Hospital, Olsztyn, Poland.
• ³² Wroclaw Medical University, Wroclaw, Poland.
• ³³ Hematology and Medical Oncology Department, University Hospital Morales Meseguer, IMIB, Murcia, Spain.
• ³⁴ Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
• ³⁵ Department of Lymphoma - Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• ³⁶ St. John's Hospital, Budapest, Hungary.
• ³⁷ Department of Medicine, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
• ³⁸ Hematology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
• ³⁹ Hematology Division Chaim Sheba Medical Center, Tel Hashomer, Israel.
• ⁴⁰ INSERM 1052/CNRS 5286, CRCL, Lyon, France.
• ⁴¹ Department of Hematology, Rydygier Specialistic Hospital, Cracow, Poland.
• ⁴² Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
• ⁴³ Department of Hematology, Holycross Cancer Center, Kielce, Poland.
• ⁴⁴ Alfred Sokolowski Specialist Hospital in Walbrzych Oncology Support Centre for Clinical Trials, Wałbrzych, Poland.
• ⁴⁵ Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland.
• ⁴⁶ Institute of Medical Sciences, College of Medical Sciences, University of Rzeszow, Rzeszow, Poland.
• ⁴⁷ Department of Hematology, Specialist Hospital No.1 in Bytom, Academy of Silesia, Faculty of Medicine, Katowice, Poland.
• ⁴⁸ University Hospital of Salamanca, Diagnostic Laboratory Unit in Hematology, University Hospital of Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
• ⁴⁹ Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
• ⁵⁰ National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.
• ⁵¹ National Centre for Tumour Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany. GMMG Study Group at University Hospital Heidelberg, Heidelberg, Germany.
• ⁵² Hematology Department, Jagiellonian University Medical College, Cracow, Poland.
• ⁵³ Hematology Department, Virgen de las Nieves University Hospital, Granada, Spain.
• ⁵⁴ Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
• ⁵⁵ Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
• ⁵⁶ Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.
• ⁵⁷ U.O. Dipartimento di Ematologia, Azienda USL Toscana Nord Ovest, Livorno, Italy.
• ⁵⁸ Department of Hematology, University Hospital, Crakow, Poland.
• ⁵⁹ Department of Hematology, University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland.
• ⁶⁰ Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal.
• ⁶¹ ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
• ⁶² Department of Clinical Immunology, the Bloodbank, Rigshospitalet, Copenhagen University Hospital, København, Denmark.
• ⁶³ Department of Hematology, Provincial Polyclinical Hospital in Torun, Torun, Poland.
• ⁶⁴ Department of Pathology, School of Medicine at the University of Alabama, Birmingham, AL, USA.
• ⁶⁵ Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. f.canzian@dkfz.de.